BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 6605378)

  • 1. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal activation of the murine immune system by an antibody to IgD. III. Ontogeny.
    Muul LM; Mond JJ; Finkelman FD
    Eur J Immunol; 1983 Nov; 13(11):900-5. PubMed ID: 6605861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal activation of the murine immune system by an antibody to IgD. VII. Demonstration of the role of nonantigen-specific T help in in vivo B cell activation.
    Finkelman FD; Smith J; Villacreses N; Metcalf ES
    J Immunol; 1984 Aug; 133(2):550-5. PubMed ID: 6203966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal activation of the murine immune system by an antibody to IgD. VI. Influence of doses of goat anti-mouse delta chain and normal goat IgG on B lymphocyte proliferation and differentiation.
    Finkelman FD; Smith J; Villacreses N; Metcalf ES
    Eur J Immunol; 1985 Apr; 15(4):315-20. PubMed ID: 3157578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal activation of the murine immune system by an antibody to IgD. X. Evidence that the precursors of IgG1-secreting cells are newly generated membrane IgD+B cells rather than the B cells that are initially activated by anti-IgD antibody.
    Finkelman FD; Goroff DK; Fultz M; Morris SC; Holmes JM; Mond JJ
    J Immunol; 1990 Dec; 145(11):3562-9. PubMed ID: 2246501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion.
    Mountz JD; Smith J; Snapper CM; Mushinski JF; Finkelman FD
    J Immunol; 1987 Oct; 139(7):2172-8. PubMed ID: 3498752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response.
    Finkelman FD; Snapper CM; Mountz JD; Katona IM
    J Immunol; 1987 May; 138(9):2826-30. PubMed ID: 2952723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
    Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
    J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
    Finkelman FD; Mond JJ; Metcalf ES
    J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig.
    Mond JJ; Schaefer M; Smith J; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2107-9. PubMed ID: 6195249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of B lymphocytes in the mouse; studies of the frequency and distribution of surface IgM and IgD in normal and immune-defective CBA/N F1 mice.
    Scher I; Berning AK; Kessler S; Finkelman FD
    J Immunol; 1980 Oct; 125(4):1686-93. PubMed ID: 6997384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ontogeny and distribution of B cells in normal and mutant immune-defective CBA/N mice: two-parameter analysis of surface IgM and IgD.
    Scher I; Titus JA; Finkelman FD
    J Immunol; 1983 Feb; 130(2):619-25. PubMed ID: 6600246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide.
    Mosier DE; Scher I; Paul WE
    J Immunol; 1976 Oct; 117(4):1363-9. PubMed ID: 789772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antigen-specific T cell help in the generation of in vivo antibody responses. I. Antigen-specific T cell help is required to generate a polyclonal IgG1 response in anti-IgD antibody-injected mice.
    Morris SC; Lees A; Inman J; Finkelman FD
    J Immunol; 1992 Dec; 149(12):3836-44. PubMed ID: 1281190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neonatal anti-delta antibody treatment on the murine immune system. II. Functional capacity of a stable sIgM+sIa+sIgD- B cell population.
    Metcalf ES; Mond JJ; Finkelman FD
    J Immunol; 1983 Aug; 131(2):601-5. PubMed ID: 6602841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.